Skip to main content
Home
  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us
  • Home
  • Affected by Cancer
    • What is cancer
    • Cancer A-Z
    • Cancer statistics
    • Interactive body map
    • Check your cancer risk online
    • Treatment
    • Living with cancer
    • Life after cancer
    • For Aboriginal and Torres Strait Islander people
    • Cancer support organisations
    • Australian cancer trials
    • Jeannie Ferris Award
    • COVID-19 and cancer
    • Culturally and Linguistically Diverse (CALD)
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children's Cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma of the skin
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary
    • Uterine sarcoma
    • Vaginal cancer
    • Vulval cancer
  • Healthy Living
    • Lifestyle & risk reduction
    • Screening
  • Clinical Best Practice
    • Cancer types
    • Psychosocial care
    • Multidisciplinary care
    • Cancer learning
    • Australian cancer trials
    • Consumer engagement
    • Shared follow-up care
  • Research & Data
    • Research
    • Grants and funding
    • Support for clinical trials
    • Cancer data
  • Publications & Resources
    • Cancer Australia publications
    • Position statements
    • Clinical Practice Guidelines
    • Cancer Australia websites
    • Cancer risk online tools
    • Other tools and resources
    • Podcasts
    • Subscribe to our eNewsletter
    • Glossary
  • About Us
    • Strategic Plan 2014-2019
    • Organisational structure
    • Accountability and reporting
    • Position Statements
    • Who we work with
    • Lung Cancer Screening enquiry
    • National Pancreatic Cancer Roadmap
    • News
    • Media
    • Campaigns & events
    • Information publication scheme
    • Reconciliation action plan
    • Employment opportunities
    • Contact us

Ovarian cancer

ovarian-mm affected-cancer/cancer-types/ovarian-cancer/what-ovarian-cancer
    • Home
    • Types
    • Statistics
    • Risk factors
    • Screening
    • Symptoms
    • Diagnosis
    • Treatment
    • Family history
    • Finding support
    • Clinical trials
    • Health professionals
    • Awareness
    • Home
    • Types
    • Statistics
    • Risk factors
    • Screening
    • Symptoms
    • Diagnosis
    • Treatment
    • Family history
    • Finding support
    • Clinical trials
    • Health professionals
    • Awareness
  1. Home
  2. Risk factors

What are the risk factors for ovarian cancer?

  • Printer-friendly version
  • A|A

A risk factor is any factor that is associated with increasing someone’s chances of developing a certain condition, such as cancer. Some risk factors are modifiable, such as lifestyle or environmental risk factors, and others cannot be modified, such as inherited factors and whether someone in the family has had cancer.

Having 1 or more risk factors does not mean that you will develop cancer. Many people have at least 1 risk factor but will never develop cancer, while others with cancer may have had no known risk factors. Even if a person with cancer has a risk factor, it is usually hard to know how much that risk factor contributed to the development of their disease.

Factors that are associated with a higher risk of developing ovarian cancer include:

  • a family history of ovarian cancer – the risk of developing ovarian cancer is higher if 1 or more blood relatives (such as mother, sister or daughter) has had ovarian cancer
  • family history of breast or colon cancer
  • a mutation in 1 of several known genes. Up to 15% of all cases of invasive ovarian cancer involve the inheritance of a mutated gene. Women who have inherited mutations in the BRCA1 or BRCA2 genes have a substantially increased risk of ovarian and breast cancer. Women with Lynch syndrome (also known as hereditary nonpolyposis colon cancer or HNPCC) also have an increased lifetime risk of ovarian cancer
  • increasing age
  • medical conditions such as endometriosis
  • use of hormone replacement therapy (HRT)
  • tobacco smoking
  • obesity

Some factors reduce the risk of developing ovarian cancer. These include:

  • having children
  • use of the oral contraceptive pill (the pill)
  • gynaecological surgery – tubal ligation (having your tubes tied)

It is not clear whether the following affect the risk of ovarian cancer:

  • Diet
  • Alcohol
  • Aspirin and non-steroidal anti-inflammatory drugs
  • Talc.

Find out more about:

  • Position Statement on Testing for ovarian cancer in asymptomatic women 
  • Frequently Asked Questions on Position Statement – Testing for Ovarian Cancer in Asymptomatic Women 
  • Position Statement on genetic testing for women diagnosed with ovarian cancer
  • Genetic testing for women diagnosed with ovarian cancer FAQs
  • Position Statement on Lifestyle risk factors and the primary prevention of cancer
  • Lifestyle and risk reduction tool
  • Breast and ovarian cancer and inherited predisposition - educational genetics factsheet from NSW Health Centre for Genetics education.

Healthcare professionals

Healthcare professionals are encouraged to visit the eviQ referral guidelines for ovarian cancer risk assessment and consideration of genetic testing for evidence-based guidance on cases that warrant referral to a family cancer clinical for assessment, based on family history.

General practitioner referral guidelines for cancer genetics assessment can be found here.

  • Last Updated
  • Relevant Links
updated: 20 October 2020 - 3:32pm
Cancer Australia, Epithelial ovarian cancer: understanding your diagnosis and treatment
Cancer Australia, Intimacy and sexuality for women with gynaecological cancer – starting a conversation
Cancer Australia Familial Risk Assesment For Breast and Ovarian Cancer
American Cancer Society, Ovarian cancer
National Cancer Institute (US), Ovarian epithelial, fallopian tube, and primary peritoneal cancer treatment (PDQ®), patient vers
National Cancer Institute (US), Ovarian germ cell tumors treatment (PDQ®), patient version
National Cancer Institute (US), Ovarian low malignant potential tumors treatment (PDQ®), patient version
National Comprehensive Cancer Network (US), NCCN guidelines for patients: ovarian cancer
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2021 - Cancer Australia